ArticleVeterinary sciences2025
Clinical Features, MRI Findings, Treatment, and Outcomes in Dogs with Haemorrhagic Myelopathy Secondary to Steroid-Responsive Meningitis-Arteritis: Nine Cases (2017-2024).
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Explorative Study of Haemostasis in Canine Steroid-Responsive Meningitis-Arteritis Using Viscoelastic Monitoring.Animals : an open access journal from MDPI · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This retrospective multicentre study investigated haemorrhagic myelopathy as a rare complication of steroid-responsive meningitis-arteritis (SRMA) in nine dogs. The affected dogs exhibited varied neurological deficits, including cervical hyperesthesia, generalised stiffness, ambulatory tetraparesis, and, in the most severe cases, paraplegia without nociception. MRI findings primarily localised haemorrhagic lesions to the thoracolumbar (T3-L3) region, with intradural-extramedullary haemorrhages being the most common type. Most cases responded favourably to immunosuppressive therapy with prednisolone, either alone or in combination with cytarabine. Surgical intervention, performed in a case of compressive extradural haemorrhage, led to a successful recovery of ambulation. Two cases presented or developed paraplegia without nociception, despite immunosuppression. These findings emphasise the importance of advanced imaging and timely therapeutic interventions in addressing atypical and severe manifestations of SRMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.